Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proquinat (Productos Químicos Naturales) is a specialized chemical company based in Mexico that focuses on the production of steroid precursors and natural extracts for the global pharmaceutical industry. Founded in 1971, the company is a leading processor of the barbasco root (Dioscorea composita), a traditional source of diosgenin. Proquinat utilizes advanced extraction and synthesis techniques to produce key intermediates such as 16-Dehydropregnenolone acetate (16-DPA), which serve as the foundation for manufacturing corticosteroids, oral contraceptives, and other hormonal therapies. Headquartered in Orizaba, Veracruz, the company operates large-scale manufacturing facilities that supply high-quality active pharmaceutical ingredient (API) intermediates to major pharmaceutical firms worldwide. Proquinat remains a critical player in the steroid supply chain, leveraging Mexico's unique botanical resources to support global health in endocrinology and reproductive medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proquinat.